We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/2/2018 09:47 | Interesting time now. Could break out into new trading range | volsung | |
26/2/2018 08:57 | Numis have a target price of 2640 made on 1 Feb.The PE to end June 18 is around the 30 mark falling to 25 in the year to June 19.The PEG is less onerous.Pretty much up with events I suppose but I'm tempted to add for the long term. | steeplejack | |
26/2/2018 08:45 | Is everything priced in? | r ball | |
26/2/2018 08:37 | Although signalled at the update stage a month or so back,these figures confirm an excellent performance with margin improvement and solid cash flow.The dividend is up 20%.OutlookDechra has performed well in the Period with solid revenue growth in EU pharmaceuticals and strong revenue growth in NA Pharmaceuticals from the existing business. This has been delivered through the consistent application of our successful strategy, converting pipeline opportunities, leveraging our strong portfolio, and expanding our geographic presence. The acquisitions of AST Farma, Le Vet and RxVet will supplement our opportunities further.Current trading continues in line with management expectations and the initial phase of integration of the AST Farma/Le Vet acquisition is progressing well. The Board remains confident that we can continue to implement our strategy and meet our expectations for the current financial year, and deliver further growth in the future. | steeplejack | |
26/2/2018 08:20 | Up on results. | r ball | |
21/2/2018 12:13 | Looks like an opportune time to buy a few more for the next leg up | volsung | |
04/2/2018 22:08 | Agreed with your comments Steeplejack, some of those boards are like kindergartens....! | huntie2 | |
30/1/2018 10:39 | Dechra Pharmaceuticals was boosted by an upgrade to buy at Jefferies. | steeplejack | |
29/1/2018 00:16 | "Few comments on good companies".......... | steeplejack | |
27/1/2018 17:06 | I must say the ADVFN bulletin boards are pretty useless. Few comments on good companies but loads in aim miners and oil explorers. Btw: a share price of less than £1 is low for a reason. | r ball | |
25/1/2018 08:23 | Yes,the small discount is very encouraging. | steeplejack | |
25/1/2018 08:06 | Not much discount with book build so appetite for shares is there | r ball | |
22/1/2018 18:19 | I suppose trading army already priced in | r ball | |
22/1/2018 18:05 | hopefully next leg up on the way to 2300p | volsung | |
18/1/2018 08:49 | Read across anyone? | r ball | |
05/1/2018 18:48 | Trading update due in 2 weeks | r ball | |
30/11/2017 11:22 | Read across from cvs? | r ball | |
05/11/2017 12:18 | Look at XLM - they can often rise | panic investor | |
03/11/2017 15:10 | Thought stocks went down a bit on XD | volsung | |
03/11/2017 14:31 | top slicing time | phillis | |
03/11/2017 14:02 | You go gurl!! | volsung |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions